7151 - 7200 of 9034 Results
Title
Year
-
OPENTitle: LRRK2 protective haplotype and full sequencing study in REM sleep behavior disorderJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 52Issue #:Start Page: 98End Page: 101Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2018.03.019Best OA location URL: https://escholarship.mcgill.ca/concern/articles/pk02cg25sCitation Count: 34
-
OPENTitle: The anti-dyskinetic effect of dopamine receptor blockade is enhanced in parkinsonian rats following dopamine neuron transplantationJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 62Issue #:Start Page: 233End Page: 240Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2013.09.021Best OA location URL: https://lup.lub.lu.se/record/4143204Citation Count: 19
-
OPENTitle: Mitochondria as sources and targets of cellular signalingJournal Name: Molecular CellPublisher: Elsevier BVVol: 86Issue #: 3Start Page: 503End Page: 521Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.molcel.2026.01.008Best OA location URL: https://doi.org/10.1016/j.molcel.2026.01.008Citation Count: 4
- Driving genotype treatment options down the right path(way)2019RESTRICTEDTitle: Driving genotype treatment options down the right path(way)Journal Name: Movement DisordersPublisher: WileyVol: 34Issue #: 12Start Page: 1811End Page: 1813Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.27893Citation Count: 1
-
OPENTitle: The role of the melanoma gene MC1R in Parkinson disease and REM sleep behavior disorderJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 43Issue #:Start Page: 180.e7End Page: 180.e13Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2016.03.029Best OA location URL: http://doi.org/10.1016/j.neurobiolaging.2016.03.029Citation Count: 15
-
OPENTitle: Machine learning-based stratification of Parkinson’s disease progression using dysautonomia symptoms and transcriptomic signaturesJournal Name: Genes & DiseasesPublisher: Elsevier BVVol: 13Issue #: 3Start Page: 101831End Page: 101831Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.gendis.2025.101831Best OA location URL: https://doi.org/10.1016/j.gendis.2025.101831Citation Count: 0
-
OPENTitle: Heritability of hippocampal subfield volumes using a twin and non-twin siblings designJournal Name: Human Brain MappingPublisher: WileyVol: 38Issue #: 9Start Page: 4337End Page: 4352Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/hbm.23654Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/hbm.23654Citation Count: 30
-
OPENTitle: Is Levodopa Response a Valid Indicator of Parkinson's Disease?Journal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 4Start Page: 948End Page: 954Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28406Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8046721Citation Count: 41
-
OPENTitle: Phosphoproteomic evaluation of pharmacological inhibition of leucine‐rich repeat kinase 2 reveals significant off‐target effects of LRRK‐2‐IN‐1Journal Name: Journal of NeurochemistryPublisher: WileyVol: 128Issue #: 4Start Page: 561End Page: 576Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/jnc.12483Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/jnc.12483Citation Count: 66
-
OPENTitle: Progressive Supranuclear Palsy in India: Insights from a Large Multicenter Clinical Cohort (Project PAIR ‐ PSP )Journal Name: Movement Disorders Clinical PracticePublisher: WileyVol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.70672Best OA location URL: https://doi.org/10.1002/mdc3.70672Citation Count: 0
- Therapeutic directions for Parkinson's disease2010RESTRICTEDTitle: Therapeutic directions for Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 25Issue #: S1Start Page: S152End Page: 4Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.22790Citation Count: 7
- Large-scale seroepidemiology uncovers nephro-urological pathologies in people with tau autoimmunity2025OPENTitle: Large-scale seroepidemiology uncovers nephro-urological pathologies in people with tau autoimmunityJournal Name: PLOS BiologyPublisher: Public Library of Science (PLoS)Vol: 23Issue #: 11Start Page: e3003488End Page: e3003488Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1371/journal.pbio.3003488Best OA location URL: https://doi.org/10.1371/journal.pbio.3003488Citation Count: 1
-
OPENTitle: Towards defining reference materials for measuring extracellular vesicle refractive index, epitope abundance, size and concentrationJournal Name: Journal of Extracellular VesiclesPublisher: WileyVol: 9Issue #: 1Start Page: 1816641End Page: 1816641Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1080/20013078.2020.1816641Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1080/20013078.2020.1816641Citation Count: 138
-
OPENTitle: Nigral Pathology Contributes to Microstructural Integrity of Striatal and Frontal Tracts in Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 38Issue #: 9Start Page: 1655End Page: 1667Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.29510Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.29510Citation Count: 18
- A multi-layered stacked classifier developed for diagnosis of Parkinson’s disease and SWEDD patients using fusion of multimodal data2025RESTRICTEDTitle: A multi-layered stacked classifier developed for diagnosis of Parkinson’s disease and SWEDD patients using fusion of multimodal dataJournal Name: Biomedical Signal Processing and ControlPublisher: Elsevier BVVol: 108Issue #:Start Page: 107924End Page: 107924Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.bspc.2025.107924Citation Count: 1
- Metabotropic glutamate receptor 4 in the basal ganglia of parkinsonian monkeys: Ultrastructural localization and electrophysiological effects of activation in the striatopallidal complex2012RESTRICTEDTitle: Metabotropic glutamate receptor 4 in the basal ganglia of parkinsonian monkeys: Ultrastructural localization and electrophysiological effects of activation in the striatopallidal complexJournal Name: NeuropharmacologyPublisher: Elsevier BVVol: 66Issue #:Start Page: 242End Page: 252Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuropharm.2012.05.017Citation Count: 42
- The Alzheimer disease BIN1 locus as a modifier of GBA-associated Parkinson disease2015RESTRICTEDTitle: The Alzheimer disease BIN1 locus as a modifier of GBA-associated Parkinson diseaseJournal Name: Journal of NeurologyPublisher: Springer Science and Business Media LLCVol: 262Issue #: 11Start Page: 2443End Page: 2447Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s00415-015-7868-3Citation Count: 27
- Time to get personal: A framework for personalized targeting of oxidative stress in neurotoxicity and neurodegenerative disease2018RESTRICTEDTitle: Time to get personal: A framework for personalized targeting of oxidative stress in neurotoxicity and neurodegenerative diseaseJournal Name: Current Opinion in ToxicologyPublisher: Elsevier BVVol: 7Issue #:Start Page: 127End Page: 132Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.cotox.2018.02.003Citation Count: 21
-
OPENTitle: Pregnenolone for the treatment of L-DOPA-induced dyskinesia in Parkinson's diseaseJournal Name: Experimental NeurologyPublisher: Elsevier BVVol: 363Issue #:Start Page: 114370End Page: 114370Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.expneurol.2023.114370Best OA location URL: https://doi.org/10.1016/j.expneurol.2023.114370Citation Count: 15
-
OPENTitle: Alpha‐synuclein RT‐QuIC in the CSF of patients with alpha‐synucleinopathiesJournal Name: Annals of Clinical and Translational NeurologyPublisher: WileyVol: 3Issue #: 10Start Page: 812End Page: 818Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/acn3.338Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/acn3.338Citation Count: 612
- Progressive dopaminergic alterations and mitochondrial abnormalities in LRRK2 G2019S knock-in mice2015OPENTitle: Progressive dopaminergic alterations and mitochondrial abnormalities in LRRK2 G2019S knock-in miceJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 78Issue #:Start Page: 172End Page: 195Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2015.02.031Best OA location URL: http://doi.org/10.1016/j.nbd.2015.02.031Citation Count: 276
-
OPENTitle: Radiosynthesis, In Vitro Characterization, and In Vivo PET Neuroimaging of [18F]F-4 for Tau Protein: A First-in-Human PET StudyJournal Name: ACS Chemical NeurosciencePublisher: American Chemical Society (ACS)Vol: 16Issue #: 6Start Page: 1182End Page: 1189Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1021/acschemneuro.4c00866Best OA location URL: https://pubs.acs.org/doi/pdf/10.1021/acschemneuro.4c00866?ref=article_openPDFCitation Count: 3
-
OPENTitle: NK cells clear α-synuclein and the depletion of NK cells exacerbates synuclein pathology in a mouse model of α-synucleinopathyJournal Name: Proceedings of the National Academy of SciencesPublisher: National Academy of SciencesVol: 117Issue #: 3Start Page: 1762End Page: 1771Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1073/pnas.1909110117Best OA location URL: https://www.pnas.org/content/pnas/117/3/1762.full.pdfCitation Count: 147
-
OPENTitle: Three-Plane–assembled Deep Learning Segmentation of GliomasJournal Name: Radiology: Artificial IntelligencePublisher: Radiological Society of North America (RSNA)Vol: 2Issue #: 2Start Page: e190011End Page: e190011Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1148/ryai.2020190011Best OA location URL: https://pubs.rsna.org/doi/pdf/10.1148/ryai.2020190011Citation Count: 25
-
OPENTitle: Self-management for people with epilepsy and a history of negative health events (SMART): A randomized controlled effectiveness trialJournal Name: Epilepsy & BehaviorPublisher: Elsevier BVVol: 171Issue #:Start Page: 110495End Page: 110495Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.yebeh.2025.110495Best OA location URL: https://commons.case.edu/facultyworks/1386Citation Count: 5
- Rasch analysis of anxiety scales in Parkinson's disease2013RESTRICTEDTitle: Rasch analysis of anxiety scales in Parkinson's diseaseJournal Name: Journal of Psychosomatic ResearchPublisher: Elsevier BVVol: 74Issue #: 5Start Page: 414End Page: 419Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.jpsychores.2013.02.009Citation Count: 30
-
OPENTitle: Autoradiography and preclinical PET studies with radiolabeled asyn-44 and ACI-12589 for imaging α-synucleinJournal Name: Journal of Parkinson’s DiseasePublisher: SAGE PublicationsVol:Issue #:Start Page: 1877718X261431108End Page: 1877718X261431108Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1177/1877718x261431108Best OA location URL: https://doi.org/10.1177/1877718x261431108Citation Count: 0
-
OPENTitle: Low plasma serotonin linked to higher nigral iron in Parkinson’s diseaseJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page: 24384End Page: 24384Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-021-03700-2Best OA location URL: https://www.nature.com/articles/s41598-021-03700-2.pdfCitation Count: 14
-
OPENTitle: Parkinson's‐Linked LRRK2 and GBA1 Mutations Modulate the Peripheral Immune Response to Pseudomonas aeruginosaJournal Name: Movement DisordersPublisher: WileyVol: 41Issue #: 3Start Page: 651End Page: 666Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.70123Best OA location URL: https://doi.org/10.1002/mds.70123Citation Count: 2
-
OPENTitle: The neuro-toxin MPTP does not prevent reproduction in marmosetsJournal Name: MNI Open ResearchPublisher: F1000 Research LtdVol: 3Issue #:Start Page: 2End Page: 2Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.12688/mniopenres.12818.2Best OA location URL: https://mniopenresearch.org/articles/3-2/v2/pdfCitation Count: 0
-
OPENTitle: Structural basis for binding of RILPL1 to TMEM55B reveals a lysosomal platform for adaptor assembly through a conserved peptide motifJournal Name: StructurePublisher: Elsevier BVVol: 34Issue #: 2Start Page: 296End Page: 310.e5Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.str.2025.11.003Best OA location URL: https://doi.org/10.1016/j.str.2025.11.003Citation Count: 1
-
OPENTitle: Rebound symptoms following battery depletion in the NIH OCD DBS cohort: Clinical and reimbursement issuesJournal Name: Brain StimulationPublisher: Elsevier BVVol: 5Issue #: 4Start Page: 599End Page: 604Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.brs.2011.10.004Best OA location URL: https://doaj.org/article/b024d8fe27934435bcc70ba31a037d69Citation Count: 50
- The PRIPS study: screening battery for subjects at risk for Parkinson's disease2012RESTRICTEDTitle: The PRIPS study: screening battery for subjects at risk for Parkinson's diseaseJournal Name: European Journal of NeurologyPublisher: WileyVol: 20Issue #: 1Start Page: 102End Page: 108Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1111/j.1468-1331.2012.03798.xCitation Count: 125
-
OPENTitle: Alpha galactosidase A activity in Parkinson's diseaseJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 112Issue #:Start Page: 85End Page: 90Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2018.01.012Best OA location URL: https://doaj.org/article/2d3c35c920664143a7a6fbfadca77476Citation Count: 81
-
OPENTitle: Association of mitochondrial genetic background with pS65-Ub in Lewy body diseaseJournal Name: Acta NeuropathologicaPublisher: Springer Science and Business Media LLCVol: 151Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s00401-026-02993-9Best OA location URL: https://link.springer.com/content/pdf/10.1007/s00401-026-02993-9.pdfCitation Count: 0
-
OPENTitle: How Vacations Affect Parkinson's DiseaseJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 10Issue #: 1Start Page: 151End Page: 153Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mdc3.13597Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.13597Citation Count: 5
-
OPENTitle: Synthesis and characterization of high affinity fluorogenic α-synuclein probesJournal Name: Chemical CommunicationsPublisher: Royal Society of Chemistry (RSC)Vol: 56Issue #: 24Start Page: 3567End Page: 3570Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1039/c9cc09849fBest OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7717557Citation Count: 37
-
OPENTitle: Clinical genetic testing in Parkinson’s disease should become part of routine patient careJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 147Issue #: 8Start Page: 2595End Page: 2597Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.1093/brain/awae181Best OA location URL: https://academic.oup.com/brain/article-pdf/147/8/2595/58712344/awae181.pdfCitation Count: 12
- PINK1 p.Leu347Pro mutations in Malays: Prevalence and illustrative cases2020RESTRICTEDTitle: PINK1 p.Leu347Pro mutations in Malays: Prevalence and illustrative casesJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 79Issue #:Start Page: 34End Page: 39Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.08.015Citation Count: 25
-
OPENTitle: Cellular Senescence Is Induced by the Environmental Neurotoxin Paraquat and Contributes to Neuropathology Linked to Parkinson’s DiseaseJournal Name: Cell ReportsPublisher: Elsevier BVVol: 22Issue #: 4Start Page: 930End Page: 940Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.celrep.2017.12.092Best OA location URL: http://www.cell.com/article/S2211124717319290/pdfCitation Count: 519
-
OPENTitle: Central Hypoventilation in Progressive Supranuclear PalsyJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 4Issue #: 1Start Page: 42End Page: 45Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.12348Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.12348Citation Count: 6
-
OPENTitle: Pathological α-synuclein perturbs nuclear integrityJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 214Issue #:Start Page: 107028End Page: 107028Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1016/j.nbd.2025.107028Best OA location URL: https://doi.org/10.1016/j.nbd.2025.107028Citation Count: 3
-
OPENTitle: Clinimetric Analysis of the Motor Section of the Progressive Supranuclear Palsy Rating Scale: Reliability and Factor AnalysisJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 3Issue #: 1Start Page: 65End Page: 67Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.12243Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.12243Citation Count: 11
-
OPENTitle: Discovery of a Pyrrolopyrimidine (JH-II-127), a Highly Potent, Selective, and Brain Penetrant LRRK2 InhibitorJournal Name: ACS Medicinal Chemistry LettersPublisher: American Chemical Society (ACS)Vol: 6Issue #: 5Start Page: 584End Page: 589Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acsmedchemlett.5b00064Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/4434483Citation Count: 57
- The highly selective mGlu 2 receptor positive allosteric modulator LY‐487,379 alleviates l ‐DOPA‐induced dyskinesia in the 6‐OHDA‐lesioned rat model of Parkinson's disease2020RESTRICTEDTitle: The highly selective mGlu 2 receptor positive allosteric modulator LY‐487,379 alleviates l ‐DOPA‐induced dyskinesia in the 6‐OHDA‐lesioned rat model of Parkinson's diseaseJournal Name: European Journal of NeurosciencePublisher: WileyVol: 51Issue #: 12Start Page: 2412End Page: 2422Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1111/ejn.14679Citation Count: 19
- DPI-289, a novel mixed delta opioid agonist / mu opioid antagonist (DAMA), has L-DOPA-sparing potential in Parkinson's disease.2017RESTRICTEDTitle: DPI-289, a novel mixed delta opioid agonist / mu opioid antagonist (DAMA), has L-DOPA-sparing potential in Parkinson's disease.Journal Name: NeuropharmacologyPublisher: Elsevier BVVol: 131Issue #:Start Page: 116End Page: 127Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuropharm.2017.11.046Citation Count: 20
- Resistance of naturally secreted α‐synuclein to proteolysis2014RESTRICTEDTitle: Resistance of naturally secreted α‐synuclein to proteolysisJournal Name: The FASEB JournalPublisher: WileyVol: 28Issue #: 7Start Page: 3146End Page: 3158Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1096/fj.13-245852Citation Count: 18
- A Failed Future2020OPENTitle: A Failed FutureJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 8Start Page: 1299End Page: 1301Publication Date:Open Access(OA) Status: OPENLicense: public-domainDOI - Digital Object Identifier: 10.1002/mds.28130Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28130Citation Count: 4
- Analysis of DNAJC13 mutations in French-Canadian/French cohort of Parkinson's disease2016RESTRICTEDTitle: Analysis of DNAJC13 mutations in French-Canadian/French cohort of Parkinson's diseaseJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 45Issue #:Start Page: 212.e13End Page: 212.e17Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2016.04.023Citation Count: 54
-
OPENTitle: Initiating pharmacotherapy in early Parkinson's diseaseJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 19Issue #: 8Start Page: 643End Page: 644Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(20)30225-8Best OA location URL: https://pure.amc.nl/en/publications/initiating-pharmacotherapy-in-early-parkinsons-disease(38fe3866-cce3-4a08-934a-d979a3cec1cc).htmlCitation Count: 5